articleJournal of Biological ChemistryJun 28, 2005HYBRID OA

Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2)

University of Leeds · Monash University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Angiotensin-converting enzyme-2 (ACE2) is a critical regulator of heart function and a cellular receptor for the causative agent of severe-acute respiratory syndrome (SARS), SARS-CoV (coronavirus). ACE2 is a type I transmembrane protein, with an extracellular N-terminal domain containing the active site and a short intracellular C-terminal tail. A soluble form of ACE2, lacking its cytosolic and transmembrane domains, has been shown to block binding of the SARS-CoV spike protein to its receptor. In this study, we examined the ability of ACE2 to undergo proteolytic shedding and investigated the mechanisms responsible for this shedding event. We demonstrated that ACE2, heterologously expressed in HEK293 cells and…

Citation impact

711
total citations
FWCI
6.12
Percentile
100%
References
41
Citations per year

Authors

8

Topics & keywords

Keywords
  • Ectodomain
  • Angiotensin-converting enzyme 2
  • Coronavirus
  • Severe acute respiratory syndrome
  • Receptor
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Tumor necrosis factor alpha
  • Tumor necrosis factor receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.